Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021)
Scholar Rock Holding (SRRK) posted quarterly Other Non-Current Liabilities of $3000.0 for Q2 2021, down 25.0% quarter-over-quarter from $4000.0 in Q1 2021.
Scholar Rock Holding (SRRK) Other Non-Current Liabilities (2017 - 2021) Analysis & Trends
Scholar Rock Holding's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3000.0 for Q2 2021.
- In Q2 2021, Other Non-Current Liabilities changed N/A year-over-year to $3000.0; the TTM figure through Jun 2021 stood at $3000.0 (changed N/A YoY), while the FY2020 annual figure was $5000.0, down 44.44% from the prior year.
- Other Non-Current Liabilities for Q2 2021 stood at $3000.0, down from $4000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $37000.0 in Q4 2017, with the low at $3000.0 in Q2 2021.
- The 4-year median for Other Non-Current Liabilities is $5000.0 (2020), against an average of $11600.0.
- Peak annual rise in Other Non-Current Liabilities reached 44.44% in 2020, while the deepest fall reached 44.44% in 2020.
- Scholar Rock Holding's Other Non-Current Liabilities stood at $37000.0 in 2017, then tumbled by 75.68% to $9000.0 in 2019, then sank by 44.44% to $5000.0 in 2020, then sank by 40.0% to $3000.0 in 2021.
- Business Quant data shows SRRK's Other Non-Current Liabilities at $3000.0 in Q2 2021, $4000.0 in Q1 2021, and $5000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Dec 31, 2017 | 37,000.00 |